-
1
-
-
25844450234
-
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation
-
Schetelig J., Kiani A., Schmitz M., et al. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Cancer Immunol Immunother 2005, 54:1043-1058.
-
(2005)
Cancer Immunol Immunother
, vol.54
, pp. 1043-1058
-
-
Schetelig, J.1
Kiani, A.2
Schmitz, M.3
-
2
-
-
34247573902
-
Graft-versus-host disease
-
Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 2007, 7:340-352.
-
(2007)
Nat Rev Immunol
, vol.7
, pp. 340-352
-
-
Shlomchik, W.D.1
-
3
-
-
69249193742
-
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
-
Socié G., Schmoor C., Bethge W.A., et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009, 10:855-864.
-
(2009)
Lancet Oncol
, vol.10
, pp. 855-864
-
-
Socié, G.1
Schmoor, C.2
Bethge, W.A.3
-
4
-
-
79959456118
-
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
-
Socié G., Schmoor C., Bethge W.A., et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 2011, 117:6375-6382.
-
(2011)
Blood
, vol.117
, pp. 6375-6382
-
-
Socié, G.1
Schmoor, C.2
Bethge, W.A.3
-
5
-
-
0032211796
-
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice
-
Murphy W.J., Welniak L.A., Taub D.D., et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998, 102:1742-1748.
-
(1998)
J Clin Invest
, vol.102
, pp. 1742-1748
-
-
Murphy, W.J.1
Welniak, L.A.2
Taub, D.D.3
-
6
-
-
0034103630
-
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets
-
Nikolic B., Lee S., Bronson R.T., et al. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 2000, 105:1289-1298.
-
(2000)
J Clin Invest
, vol.105
, pp. 1289-1298
-
-
Nikolic, B.1
Lee, S.2
Bronson, R.T.3
-
7
-
-
33745321276
-
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
-
Komiyama Y., Nakae S., Matsuki T., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573.
-
(2006)
J Immunol
, vol.177
, pp. 566-573
-
-
Komiyama, Y.1
Nakae, S.2
Matsuki, T.3
-
8
-
-
36549019912
-
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model
-
Hirota K., Yoshitomi H., Hashimoto M., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007, 204:2803-2812.
-
(2007)
J Exp Med
, vol.204
, pp. 2803-2812
-
-
Hirota, K.1
Yoshitomi, H.2
Hashimoto, M.3
-
9
-
-
36348980530
-
Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease
-
Chen X., Vodanovic-Jankovic S., Johnson B., et al. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007, 110:3804-3813.
-
(2007)
Blood
, vol.110
, pp. 3804-3813
-
-
Chen, X.1
Vodanovic-Jankovic, S.2
Johnson, B.3
-
10
-
-
59649098784
-
IL-17 contributes to CD4-mediated graft-versus-host disease
-
Kappel L.W., Goldberg G.L., King C.G., et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009, 113:945-952.
-
(2009)
Blood
, vol.113
, pp. 945-952
-
-
Kappel, L.W.1
Goldberg, G.L.2
King, C.G.3
-
11
-
-
70449494642
-
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2 and Th17 cells in graft-versus-host disease
-
Yi T., Chen Y., Wang L., et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2 and Th17 cells in graft-versus-host disease. Blood 2009, 114:3101-3112.
-
(2009)
Blood
, vol.114
, pp. 3101-3112
-
-
Yi, T.1
Chen, Y.2
Wang, L.3
-
12
-
-
60849118676
-
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
-
Carlson M.J., West M.L., Coghill J.M., et al. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009, 113:1365-1374.
-
(2009)
Blood
, vol.113
, pp. 1365-1374
-
-
Carlson, M.J.1
West, M.L.2
Coghill, J.M.3
-
13
-
-
75149118145
-
T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease
-
Iclozan C., Yu Y., Liu C., et al. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16:170-178.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 170-178
-
-
Iclozan, C.1
Yu, Y.2
Liu, C.3
-
14
-
-
52649136967
-
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease
-
Yi T., Zhao D., Lin C.L., et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 2008, 112:2101-2110.
-
(2008)
Blood
, vol.112
, pp. 2101-2110
-
-
Yi, T.1
Zhao, D.2
Lin, C.L.3
-
15
-
-
80855128779
-
Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice
-
Yu Y., Wang D., Liu C., et al. Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice. Blood 2011, 118:5011-5020.
-
(2011)
Blood
, vol.118
, pp. 5011-5020
-
-
Yu, Y.1
Wang, D.2
Liu, C.3
-
16
-
-
73349105621
-
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation
-
Dander E., Balduzzi A., Zappa G., et al. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009, 88:1261-1272.
-
(2009)
Transplantation
, vol.88
, pp. 1261-1272
-
-
Dander, E.1
Balduzzi, A.2
Zappa, G.3
-
17
-
-
84863779459
-
Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease
-
Bossard C., Malard F., Arbez J., et al. Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia 2012, 26:1471-1474.
-
(2012)
Leukemia
, vol.26
, pp. 1471-1474
-
-
Bossard, C.1
Malard, F.2
Arbez, J.3
-
18
-
-
78650442609
-
Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells
-
Broady R., Yu J., Chow V., et al. Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood 2010, 116:5748-5751.
-
(2010)
Blood
, vol.116
, pp. 5748-5751
-
-
Broady, R.1
Yu, J.2
Chow, V.3
-
19
-
-
77956538770
-
Th17/Treg ratio in human graft-versus-host disease
-
Ratajczak P., Janin A., Peffault de Latour R., et al. Th17/Treg ratio in human graft-versus-host disease. Blood 2010, 116:1165-1171.
-
(2010)
Blood
, vol.116
, pp. 1165-1171
-
-
Ratajczak, P.1
Janin, A.2
Peffault de Latour, R.3
-
20
-
-
77958545437
-
Interleukin-17-producing cells increase among CD4+ lymphocytes before overt manifestation of acute graft-versus-host disease
-
Dlubek D., Turlej E., Sedzimirska M., et al. Interleukin-17-producing cells increase among CD4+ lymphocytes before overt manifestation of acute graft-versus-host disease. Transplant Proc 2010, 42:3277-3279.
-
(2010)
Transplant Proc
, vol.42
, pp. 3277-3279
-
-
Dlubek, D.1
Turlej, E.2
Sedzimirska, M.3
-
21
-
-
34547734621
-
Phenotypic and functional features of human Th17 cells
-
Annunziato F., Cosmi L., Santarlasci V., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
-
(2007)
J Exp Med
, vol.204
, pp. 1849-1861
-
-
Annunziato, F.1
Cosmi, L.2
Santarlasci, V.3
-
22
-
-
73949121455
-
Plasticity of T-cell phenotype and function: the T helper type 17 example
-
Peck A., Mellins E.D. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2010, 129:147-153.
-
(2010)
Immunology
, vol.129
, pp. 147-153
-
-
Peck, A.1
Mellins, E.D.2
-
23
-
-
77957032994
-
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment
-
Nistala K., Adams S., Cambrook H., et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci USA 2010, 107:14751-14756.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 14751-14756
-
-
Nistala, K.1
Adams, S.2
Cambrook, H.3
-
24
-
-
34250777773
-
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
-
Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007, 21:1387-1394.
-
(2007)
Leukemia
, vol.21
, pp. 1387-1394
-
-
Mohty, M.1
-
26
-
-
0026632557
-
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
-
O'Keefe S.J., Tamura J., Kincaid R.L., et al. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992, 357:692-694.
-
(1992)
Nature
, vol.357
, pp. 692-694
-
-
O'Keefe, S.J.1
Tamura, J.2
Kincaid, R.L.3
-
27
-
-
44549083419
-
Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis
-
Zhang C., Zhang J., Yang B., Wu C. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. Cytokine 2008, 42:345-352.
-
(2008)
Cytokine
, vol.42
, pp. 345-352
-
-
Zhang, C.1
Zhang, J.2
Yang, B.3
Wu, C.4
-
28
-
-
84859846873
-
A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group
-
George B., Kerridge I.H., Gilroy N., et al. A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group. Transpl Infect Dis 2012, 14:141-148.
-
(2012)
Transpl Infect Dis
, vol.14
, pp. 141-148
-
-
George, B.1
Kerridge, I.H.2
Gilroy, N.3
-
29
-
-
74049134371
-
Mixed results with modulation of Th-17 cells in human autoimmune diseases
-
Steinman L. Mixed results with modulation of Th-17 cells in human autoimmune diseases. Nat Immunol 2009, 11:41-44.
-
(2009)
Nat Immunol
, vol.11
, pp. 41-44
-
-
Steinman, L.1
-
30
-
-
84860888650
-
Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD
-
Pidala J., Perez L., Beato F., Anasetti C. Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD. Bone Marrow Transplant 2012, 47:747-748.
-
(2012)
Bone Marrow Transplant
, vol.47
, pp. 747-748
-
-
Pidala, J.1
Perez, L.2
Beato, F.3
Anasetti, C.4
|